KEAP1 and neoplasm: Specifically, the loss of ADAR1 leads to the upregulation of Keap1, which inhibits Nrf2, resulting in the accumulation of reactive oxygen species (ROS), enhanced apoptosis, and impaired tumor cell proliferation (86).